http://orcid.org/0000-0002-9874-3093
References
- Calderón-Aranda ES, Dehesa-Dávila M, Chávez-Haro A, et al. Scorpion stings and their treatment in Mexico. In: Bon C, Goyffon M, editors. Envenomings and their treatments. Lyon (France): Fondation Marcel Mérieux; 1996. p. 311–320.
- Curry SC, Vance MV, Ryan PJ, et al. Envenomation by the scorpion Centruroides sculpturatus. J Toxicol Clin Toxicol. 1983–1984;21:417–449.
- LoVecchio F, McBride C. Scorpion envenomations in young children in Central Arizona. J Toxicol Clin Toxicol. 2003;41:937–940.
- U. S. Food & Drug Administration. Package Insert – Anascorp; July 2011 [accessed 2018 Jul 18]. Available from: https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-bio-gen/documents/document/ucm266725.pdf
- Boyer LV, Theodorou AA, Berg RA. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med. 2009;360:2090–2098.
- Riley BD, LoVecchio F, Pizon AF. Lack of scorpion antivenom leads to increased pediatric ICU admissions. Ann Emerg Med. 2006;47:398–399.
- O'Connor A, Ruha A-M. Clinical course of bark scorpion envenomation managed without antivenom. J Med Toxicol. 2012;8:258–262.
- Gibly R, Williams M, Walter FG, et al. Continuous intravenous midazolam infusion for Centruroides exilicauda scorpion envenomation. Ann Emerg Med. 1999;34:620–625.
- Boyer L, Degan J, Ruha A-M, et al. Safety of intravenous equine F(ab’)2: insights following clinical trials involving 1534 recipients of scorpion antivenom. Toxicon. 2013;76:386–393.
- Boyer LV, Theodorou AA, Chase PB, et al. Effectiveness of Centruroides scorpion antivenom compared to historical controls. Toxicon. 2013;76:377–385.
- Armstrong EP, Bakall M, Skrepnek GH, et al. Is scorpion antivenom cost-effective as marketed in the United States? Toxicon. 2013;76:394–398.
- Sinha M, Quan D, McDonald FW, et al. Cost minimization analysis of different strategies of management of clinically significant scorpion envenomation among pediatric patients. Pediatr Emer Care. 2016;32:856–862.
- Coorg V, Levitan RD, Gerkin RD, et al. Clinical presentation and outcomes associated with different treatment modalities for pediatric bark scorpion envenomation. J Med Toxicol. 2017;13:66–70.
- Isbister GK, Bawaskar HS. Scorpion envenomation. N Engl J Med. 2014;371:457–463.
- Chippaux JP, Goyffon M. Epidemiology of scorpionism: a global appraisal. Acta Trop. 2008;107:71–79.
- Kang AM, Brooks DE. Nationwide scorpion exposures reported to US Poison Control Centers from 2005 to 2015. J Med Toxicol. 2017;13:158–165.
- Kang AM, Brooks DE. Geographic distribution of scorpion exposures in the United States, 2010–2015. Am J Public Health. 2017;107:1958–1963.
- Abroug F, ElAtrous S, Nouria S, et al. Serotherapy in scorpion envenomation: a randomised controlled trial. Lancet. 1999;354:906–909.
- Bawaskar HS, Bawaskar PH. Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial. BMJ. 2011;342:c7136–c7136.
- Pandi K, Krishnamurthy S, Srinivasaraghavan R, et al. Efficacy of scorpion antivenom plus prazosin versus prazosin alone for Mesobuthus tamulus scorpion sting envenomation in children: a randomised controlled trial. Arch Dis Child. 2014;99:575–580.
- Jorge MT, Cardoso JL, Castro SC, et al. A randomized 'blinded' comparison of two doses of antivenom in the treatment of Bothrops envenoming in São Paulo, Brazil. Trans R Soc Trop Med Hyg. 1995;89:111–114.